Home › Strategic Acquisition Advances Regenerative Medicine
 

Keywords :   


Strategic Acquisition Advances Regenerative Medicine

2013-06-19 06:00:00| Industrial Newsroom - All News for Today

Instron, a leading provider of testing equipment solutions designed to evaluate mechanical properties of materials and components, is pleased to announce the acquisition of Tissue Growth Technologies (TGT), a premier supplier of commercial bioreactors to grow and stimulate developing tissues. <br /> <br /> TGT will become part of the Instron division of ITWs Test and Measurement business. In partnership, we are excited to offer an instrumentation platform that is uniquely designed to cater to ...

Tags: medicine strategic acquisition advances

Category:Industrial Goods and Services

Latest from this category

All news
18.06A Request From the A League of Their Own Womens Special Interest Group
18.06Next MANAchat Series is Scheduled for the Week of August 5
17.06New Federal Government Filing Requirement Regarding Ownership of LLCs and Corporations
17.06Manufacturers Reps That Sell to International Customers June 26 Networking Event
17.06Avoid $591 Daily Penalty From the U.S. Treasury Department
Industrial Goods and Services »
30.06Atlantic Tropical Weather Outlook
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 6A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Wind Speed Probabilities Number 6
30.06Hurricane Beryl Public Advisory Number 6
More »